ARCHIVES

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Rogers Indicates He May Let Training Grant Bill Die

March 29, 1974

NIH Biennial Report Offers Research Portrait

September 24, 2010

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

October 11, 1996

Job Discrimination Survey Completed, But NCI Still Trying To Interpret I; Payments May Be Held Up

August 19, 1977

Local Labs Not As Accurate As Central Testing For HER2

August 30, 2002